Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

41.35 +2.10 (+5.36%)
Delayed Quote Updated: 10:57 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Lots Of Deal News ↗
Today Didi, a Chinese ride-hailing stock is doing its IPO reportedly at above the level projected in its application. 
Via Talk Markets
Topics Initial Public Offering
News headline image
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly... 
Via Benzinga
News headline image
JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst ↗
Over the weekend, Johnson & Johnson (NYSE:JNJ) reached a ... 
Via Benzinga
News headline image
Teva and Bioeq Announce Commercial Partnership for Biosimilar
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide ↗
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk... 
Via Talk Markets
News headline image
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide ↗
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,... 
Via Benzinga
News headline image
Summer Friday ↗
The stock market tried for another record after yesterday's late blowout over the infrastructure deal. 
Via Talk Markets
News headline image
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Reconsidered Boom ↗
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
News headline image
Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
The First Day Of Summer And Prime Day ↗
The bull is back in business today. 
Via Talk Markets
News headline image
10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
Via Benzinga
News headline image
Two Rate Hikes In 2023 ↗
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
News headline image
Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Continued Uncertainty ↗
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all. 
Via Talk Markets
News headline image
Dreary Day ↗
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. 
Via Talk Markets
News headline image
Happy Friday ↗
The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer. 
Via Talk Markets
News headline image
Unheeding Markets ↗
Today oil prices rose over $70. 
Via Talk Markets
News headline image
Wednesday News And Catch-Up ↗
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
News headline image
Juvenile Investing Mob ↗
Tech stocks did well in Europe but not in the US. The data are unconvincing. 
Via Talk Markets
News headline image
FDA surprise ↗
The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year. 
Via Talk Markets
News headline image
A Better Switch ↗
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase. 
Via Talk Markets
News headline image
Fan Hit ↗
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
News headline image
New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headache Society (AHS) Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva’s Longstanding Heritage in the Management of Migraine
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
A Catch-Up Day ↗
OPEC had a virtual meeting about rising demand for oil and rising demand that oil companies cut their carbon footprint. 
Via Talk Markets
News headline image
3 Cheap Pharmaceutical Stocks to Grab Now ↗
The pharmaceutical industry has been the beneficiary of significant investor attention amid the COVID-19 pandemic as society turned to its products to fight the coronavirus. 
Via Talk Markets
News headline image
Good Times For Gold ↗
Gold is rising some more, in part as an alternative to crypto. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.